New Study to Evaluate Effect of an Investigational Drug on Gastrointestinal Dysfunction in Children with Autism
Thursday December 1, 10:00 am ET
SACRAMENTO, Calif., Dec. 1 /PRNewswire/ -- The UC Davis MIND Institute is one of twelve trial sites participating in a research study to evaluate an investigational medication for the treatment of persistent gastrointestinal (GI) dysfunction in children with Autism.
Frequently children with autism experience persistent GI problems, ranging from mild to moderate degrees of inflammation in both the upper and lower intestinal tract. These problems have an impact on the autism community, which currently has limited information on the cause and appropriate treatments.
To be considered for participation in the study, and experience some of the following symptoms:
* Chronic diarrhea or constipation
* Abdominal pain
Research volunteers will receive study medication and medical care at no cost to the family.
To find out mare about the study as well as additional inclusion/exclusion criteria, please contact Norman Brule, 916-734-7732.